Portuguese Society of Microbiology (PT-SPM)
The SPM aims are to promote and develop research, teaching and applications of microbiology and related sciences in Portugal, fostering the interaction between SPM members and encouraging the communication between microbiologists.
Since 2001 and every two years, SPM , together with the Portuguese Society for Biotechnology, organizes the National Congress of Microbiology and Biotechnology (Microbiotec). This joint meeting includes interdisciplinary sessions across several thematic areas in Microbiology and Biotechnology.
Microbiologia, the Magazine of SPM, is an online open access journal aimed at unveiling microbiology R&D activities in Portugal or promoted by Portuguese researchers, in the scientific, academic and professional communities.
Membership location: international
Membership scope: national or foreign individuals with professional activity (research, applied research, practice, technical activity, teaching) in the field of microbiology or related sciences.
|Member type||fee (currency)||Notes|
|Full member||30 (€)||Application supported by two SPM full members or curriculum vitae approved by SPM Directive Board|
|Student member (BSc and MSc cycle)||10 (€)|
|Student member (PhD cycle)||20 (€)|
|Retired and Emeritus member||10 (€)|
How to join
Contact point: FEMS Delegate
Request additional contact details via email@example.com
member of FEMS since 16 November 1974
The Portuguese Society of Microbiology (SPM) was created on December 1973 as a scientific non- profit association.
SPM became a member of FEMS in 1974, is an affiliated member of IUMS (International Union of Microbiological Societies) since 1982 and has integrated ALAM (Latin American Association of Microbiology) in 2010.
Currently with more than 200 members, SPM wants to attract more researchers and active professionals in the different fields of microbiology, with particular emphasis for young graduates, masters and PhDs.
FEMS Yeast Research is proud to present this latest thematic issue on yeast pathogenesis and drug resistance. In the past few decades, genetics and genomics studies have uncovered traits underlying the pathogenicity and drug resistances of pathogenic yeast. However, we still have a lot to uncover about the complex mechanisms used by different species to thrive in the human host, and much to do to convert this knowledge into improved clinical treatments. This thematic issue highlights the importance of the diversity of genome-scale approaches to unravel the intricate nature of pathogenesis and drug resistance in pathogenic yeasts, bringing together a diverse range of fascinating views on antifungal drug resistance.